Test of DBLG1 closed-loop insulin delivery for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests how well a new closed-loop insulin delivery system (DBLG1) helps manage blood sugar and improves quality of life for adults with type 1 diabetes. If you are starting this system, the study will track your glucose control and ask about your daily experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You are 18 years old or older.
- You are about to start using the DBLG1 system (a closed-loop insulin pump).
- You are able to sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.